Markets:

Overview

News

Currencies

International

Treasuries

Jasper Therapeutics, Inc. - Class A Common Stock (NQ:JSPR)

1.750 +0.030 (+1.74%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Jasper Therapeutics, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

18 Stocks Moving in Thursday's Pre-Market Session ↗

October 14, 2021

Gainers TSR, Inc. (NASDAQ: TSRI) rose 40.2% to $12.89 in pre-market trading after the company reported record revenue for its first quarter. Cemtrex, Inc. (NASDAQ: CETX) rose 34....

Via Benzinga

50 Biggest Movers From Yesterday ↗

October 14, 2021

Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares surged 105.1% to close at $14.79 on Wednesday after Oppenheimer initiated coverage on the stock with an Outperform rating...

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Jumps 100 Points; Jasper Therapeutics Shares Spike Higher ↗

October 13, 2021

Toward the end of trading Wednesday, the Dow traded up 0.06% to 34,398.86 while the NASDAQ rose 0.70% to 14,566.72. The S&P also rose, gaining 0.31% to 4,364.35. The U.S. has...

Via Benzinga

Topics Stocks

Dow, S&P 500 Head Toward Fourth-Straight Day of Losses ↗

October 13, 2021

Stocks are mixed at midday, as Wall Street looks over a fresh batch of inflation data and corporate earnings reports.

Via Talk Markets

Topics Stocks

Mid-Day Market Update: Gold Surges 2%; Neuronetics Shares Plunge ↗

October 13, 2021

Midway through trading Wednesday, the Dow traded down 0.43% to 34,229.72 while the NASDAQ rose 0.40% to 14,524.02. The S&P also fell, dropping 0.10% to 4,346.21. The U.S. has...

Via Benzinga

Topics Stocks

40 Stocks Moving In Wednesday's Mid-Day Session ↗

October 13, 2021

Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares jumped 113% to $15.36 after Oppenheimer initiated coverage on the stock with an Outperform rating and a $21 price target...

Via Benzinga

JSPR Stock: The Bullish Call That Has Biotech Play Jasper Therapeutics Rocketing 105% Today ↗

October 13, 2021

Jasper Therapeutics (JSPR) stock is taking off on Wednesday thanks to a new bullish call from Oppenheimer analyst Jay Olson.

Via InvestorPlace

Why Jasper Therapeutics Stock Is Jumping Today ↗

October 13, 2021

A Wall Street investment bank just started following the company with a very upbeat outlook.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2021 ↗

October 13, 2021

Upgrades DA Davidson upgraded the previous rating for Columbia Banking System Inc (NASDAQ:

Via Benzinga

Why Jasper Therapeutics Stock Is Soaring Today ↗

October 13, 2021

Jasper Therapeutics Inc (NASDAQ: JSPR) is surging higher Wednesday after Oppenheimer analyst Jay Olson initiated coverage on the stock with an Outperform...

Via Benzinga

Mid-Morning Market Update: Markets Mixed; JPMorgan Posts Upbeat Earnings ↗

October 13, 2021

Following the market opening Wednesday, the Dow traded down 0.36% to 34,254.62 while the NASDAQ rose 0.27% to 14,505.47. The S&P also fell, dropping 0.07% to 4,347.49. The U.S...

Via Benzinga

Topics Stocks

20 Stocks Moving in Wednesday's Pre-Market Session ↗

October 13, 2021

Gainers Puxin Limited (NYSE: NEW) rose 52.1% to $0.6901 in pre-market trading after dipping 24% on Tuesday. Jasper Therapeutics, Inc. (NASDAQ: JSPR) rose 38% to $9.95 in pre-...

Via Benzinga

36 Biggest Movers From Yesterday ↗

October 06, 2021

Gainers Bit Digital, Inc. (NASDAQ: BTBT) shares climbed 36.4% to settle at $10.35 on Tuesday amid an increase in the price of Bitcoin and Ethereum. Zeta Global Holdings Corp. (...

Via Benzinga

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology ↗

October 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal ↗

October 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...

Via Benzinga

30 Stocks Moving In Monday's Mid-Day Session ↗

October 04, 2021

Gainers Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares jumped 71.1% to $26.69 after the company announced its phase 2 study of XEN1101 for the treatment of epilepsy met all...

Via Benzinga

18 Stocks Moving in Monday's Pre-Market Session ↗

October 04, 2021

Gainers CohBar, Inc. (NASDAQ: CWBR) rose 22.8% to $1.13 in pre-market trading after dropping over 4% on Friday. Farmmi, Inc.. (NASDAQ: FAMI) rose 13% to $0.3995 in pre-market...

Via Benzinga

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO ↗

October 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...

Via Benzinga

The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug ↗

September 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (...

Via Benzinga

52 Biggest Movers From Yesterday ↗

September 30, 2021

Gainers Paltalk, Inc. (NASDAQ: PALT) shares jumped 60.1% to close at $8.39 on Wednesday. Smart Share Global Limited (NASDAQ: EM) jumped 36.2% to close at $3.91. Smart Share...

Via Benzinga

50 Biggest Movers From Yesterday ↗

September 28, 2021

Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares surged 50% to close at $3.60 on Monday after the company said its subsidiary, Skypersonic, Inc, won a five-year contract from...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.